checkAd
    Startseite > Aktien > Virpax Pharmaceuticals > Nachrichten
    Virpax Pharmaceuticals Aktie
    0,7000
     
    USD
    -4,11 %
    -0,0300 USD
    Letzter Kurs 02:00:00 Nasdaq
    0,6901
     
    USD
    4.600 STK
    Geldkurs 31.05.24
    0,7000
     
    USD
    100 STK
    Briefkurs 31.05.24
    ISIN: US9282512063 · SYM: VRPX · USA

    Neueste Nachrichten

    Virpax Pharmaceuticals to Present at 2024 BIO International Convention
    29.05.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Announces Pricing of $2.25 Million Public Offering
    15.05.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
    13.05.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Announces Results of Maximum Tolerated Dose Study for Probudur
    30.04.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Reports 2023 Year-End Results
    26.03.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
    27.02.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
    27.02.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
    07.02.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
    29.12.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
    17.11.23 · Business Wire (engl.) · Virpax Pharmaceuticals
     Virpax Pharmaceuticals Announces Leadership Transition
    17.11.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
    15.11.23 · Business Wire (engl.) · Virpax Pharmaceuticals